WEBULL
News
TLX
8.03
-0.86%
-0.07
TLX Deadline: TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm
PR Newswire · 2d ago
Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX) Seeking Recovery for Investors - Contact Levi & Korsinsky
PR Newswire · 2d ago
Telix Pharmaceuticals Faces Investor Class Action Over Alleged Securities Fraud
Reuters · 2d ago
Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR Newswire · 4d ago
21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures
PR Newswire · 4d ago
Shareholders that lost money on Telix Pharmaceuticals Ltd.(TLX) should contact Levi & Korsinsky about pending Class Action - TLX
PR Newswire · 5d ago
Investors File Class Action Lawsuit Against Telix Pharmaceuticals Ltd
Reuters · 6d ago
21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures
PR Newswire · 6d ago
HC Wainwright & Co. Reiterates Buy on Telix Pharmaceuticals, Maintains $20 Price Target
Benzinga · 6d ago
Weekly Report: what happened at TLX last week (1215-1219)?
Weekly Report · 6d ago
The Gross Law Firm Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - TLX
PR Newswire · 6d ago
Telix Reports Positive Phase 3 Results For Illuccix Prostate Cancer Imaging Trial In China
NASDAQ · 6d ago
BUZZ-Australia's Telix Pharmaceuticals rises on positive outlook for innovative drugs
Reuters · 12/21 23:34
Telix Pharmaceuticals Advances FDA Resubmissions for TLX101-CDx and TLX250-CDx
Reuters · 12/21 21:38
PRECISION MEDICINE PORTFOLIO UPDATE: ILLUCCIX CHINA PHASE 3 STUDY, TLX101-CDX AND TLX250-CDX FDA RESUBMISSIONS
Reuters · 12/21 21:38
TLX Deadline: TLX Investors with Losses in Excess of $100K Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm
PR Newswire · 12/21 14:06
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Telix Pharmaceuticals
Barchart · 12/21 09:14
Telix Pharmaceuticals Faces Investor Class Action Over Securities Fraud Allegations
Reuters · 12/19 22:30
More
Webull provides a variety of real-time TLX stock news. You can receive the latest news about Telix Pharmaceuticals Ltd ADR through multiple platforms. This information may help you make smarter investment decisions.
About TLX
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.